Metraipolis › archive › dc_7c349bf5930c

Peripheral Blood Biomarkers Predict Outcomes in Advanced Cancers Treated With Anti-PD-1 Therapy — Europe PMC PMID:42093111

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42093111
DOI
10.1002/iid3.70402
License (as archived)
solo-consultazione
Archived
2026-11-02T19:58:48.932Z
SHA-256 of the archived text
3d812c7d14394f5475255927c675f6fcb2329e4d5ca6cba8e76fa317ef8635e2
Stable URL of this page
https://metraipolis.com/documento/dc_7c349bf5930c

How to cite

Peripheral Blood Biomarkers Predict Outcomes in Advanced Cancers Treated With Anti-PD-1 Therapy — Europe PMC PMID:42093111 — Europe PMC (en), https://europepmc.org/article/MED/42093111 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c349bf5930c (Metraipolis archive dc_7c349bf5930c, sha256 3d812c7d14394f5475255927c675f6fcb2329e4d5ca6cba8e76fa317ef8635e2)
BibTeX
@misc{dc7c349bf5930c,
  title = {Peripheral Blood Biomarkers Predict Outcomes in Advanced Cancers Treated With Anti-PD-1 Therapy — Europe PMC PMID:42093111},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42093111},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c349bf5930c; sha256 3d812c7d14394f5475255927c675f6fcb2329e4d5ca6cba8e76fa317ef8635e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42093111. Agents can read the archived copy with the MCP tool read_document.